Leuprolide

Especificaciones

53714-56-0Número CAS

633-395-9Número CE

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxoprNombre IUPAC

C59H84N16O12Fórmula química

1209.4 g/molPeso molecular

Leuprorelin; leuprolide; 53714-56-0; Leuprorelina; Leuproreline; Leuprorelinum; Leuporelin; (-)-leuprolide; Leuprorelin slow release; EFY6W0M8TG; TAP-144 FREE BASE; CKD-841; ABBOTT-43818 FREE BASE; NSC-377526; CHEBI:6427; DTXSID50872411; pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5; RefChem:55465; DTXCID00820063; L02AE02; 6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig); 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig); (2S)-1-((2S)-5-carbamimidamido-2-(((2S)-2-(((2R)-2-(((2S)-2-(((2S)-1,3-dihydroxy-2-(((2S)-1-hydroxy-2-(((2S)-1-hydroxy-2-((hydroxy((2S)-5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene)amino)-3-(1H-imidazol-5-yl)propylidene)amino)-3-(1H-indol-3-yl)propylidene)amino)propylidene)amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino)-1-hydroxy-4-methylpentylidene)amino)-1-hydroxy-4-methylpentylidene)amino)pentanoyl)-N-ethylpyrrolidine-2-carboximidic acid; MFCD00167544; C59H84N16O12; 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide; Leuprorelin acetate (JAN); Leuprolide acetate (USAN); Leuprolide TFA; LEUPROLIDE [USAN]; LEUPRORELIN [INN]; Leuprolide acetate salt; Leuprorelin [INN:BAN]; UNII-EFY6W0M8TG; Leuproreline [INN-French]; Leuprorelinum [INN-Latin]; Leuprorelina [INN-Spanish]; Leuprorelin?; CCRIS 8462; Leuprorelin CRS; HSDB 6518; NSC 377526; LEUPROLIDE [MI]; LEUPROLIDE [HSDB]; LEUPROLIDE [VANDF]; SCHEMBL4585; LEUPRORELIN [MART.]; LEUPRORELIN [WHO-DD]; SCHEMBL172917; GTPL1175; CHEMBL1201199; SCHEMBL30983092; GFIJNRVAKGFPGQ-LIJARHBVSA-N; LEUPRORELIN [EP MONOGRAPH]; MSK10725; (D-Leu(sup 6),des-gly-NH2(sup 10),pro-ethylamide(sup 9))-GNRH; (D-Leu(sup 6),des-gly-NH2(sup 10),pro-ethylamide(sup 9))-LHRH; BDBM50247891; BDBM50369395; EBC-27540; EX-A14831; FP-001; AKOS015892744; AKOS030213246; AKOS037515838; CCG-270656; CS-4947; DB00007; HS-2016; NCGC00485984-01; (2S)-1-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2R)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-4-methylpentanamido]pentanoyl]-N-ethylpyrrolidine-2-carboxamide; AC-38352; DA-64932; HY-12553; Leuprolide acetate salt, >=98% (HPLC); C75519; pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt; EN300-7481165; Fensolvi (leuprolide acetate injectable suspension); Q907160; BRD-K26323068-001-01-8; Leuprolide acetate, United States Pharmacopeia (USP) Reference Standard; 1-9-Luteinizing hormone-releasing factor (swine), 6-D-leucine-9-(N-ethyl-L-prolinamide)-; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-Lprolinamide; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamideSinónimos